Skip to main content
Clinical Trials/NCT06370481
NCT06370481
Recruiting
N/A

HIV, Equity, and Addiction Training (HEAT) Program

University of Alabama at Birmingham2 sites in 1 country30 target enrollmentJanuary 29, 2026

Overview

Phase
N/A
Intervention
Telemedicine
Conditions
Substance Use Disorders
Sponsor
University of Alabama at Birmingham
Enrollment
30
Locations
2
Primary Endpoint
Percent of participants who have a follow-up healthcare visit
Status
Recruiting
Last Updated
2 months ago

Overview

Brief Summary

This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.

Detailed Description

The contemporary drug crisis and the COVID-19 pandemic have exposed the complex syndemics of addiction and infectious diseases: rising rates of substance use disorder (SUD) have outpaced our ability to respond with a limited healthcare workforce and public health capacity. SUD is increasing in those living with and at risk for HIV, and infectious consequences of SUD, like hepatitis C, have continued, unmitigated, in rural parts of the U.S. where many states lack Medicaid expansion, syringe service programs, and public health infrastructure to respond to the drug crisis and comorbid infections. Systemic racism and regressive policies in the Deep South criminalize people who use drugs, creating additional barriers to care, HIV prevention, and addiction treatment. As a result, people who use drugs rarely receive comprehensive addiction and HIV treatment. Yet telemedicine has the potential to overcome these barriers and bypass the constraints of a brick-and-mortar clinic to link vulnerable people, including those with HIV, to care. Although telemedicine has become mainstream in recent years, few studies have evaluated telemedicine for SUD in the Deep South from the perspective of patients and providers.

Registry
clinicaltrials.gov
Start Date
January 29, 2026
End Date
June 1, 2029
Last Updated
2 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ellen Eaton

Associate Professor

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • Receiving services at HIV clinics in Alabama
  • Reported opioid and/or stimulant misuse
  • 18 years of age or older

Exclusion Criteria

  • Receipt of SUD clinical care other than through HIV provider/clinic in the last 3 months
  • Inability to engage in interviews independently without support (e.g., cognitive impairment)
  • Currently psychotic
  • Actively suicidal: presents with a suicide attempt or suicidal ideation

Arms & Interventions

Patients living with HIV and substance use

Patients living with HIV and substance use, aged 18 and over. These participants are receiving services at HIV clinics in Alabama and must have reported opioid and/or stimulant misuse.

Intervention: Telemedicine

Patients living with HIV and substance use

Patients living with HIV and substance use, aged 18 and over. These participants are receiving services at HIV clinics in Alabama and must have reported opioid and/or stimulant misuse.

Intervention: Standard of care

Outcomes

Primary Outcomes

Percent of participants who have a follow-up healthcare visit

Time Frame: 1 month, 2 months, 3 months

Follow up visit for care (either telemedicine or in person)

Study Sites (2)

Loading locations...

Similar Trials